Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Alexey Stukalov, Virginie Girault, Vincent Grass, +27

Nature

Proteomic TechnologyMedicineMultilevel Proteomics RevealsVirologyOmics +4

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion

Georg Jocher, Vincent Grass, Sarah K. Tschirner, +14

EMBO Reports

Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing

Jana Zecha, Chien‐Yun Lee, Florian Bayer, +8

Molecular & Cellular Proteomics

Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

Shubhankar Ambike, Cho‐Chin Cheng, Martin Feuerherd, +14

Nucleic Acids Research

Viral ReplicationGenomic Sars-cov-2 RnaSirna-based TherapiesImmunologyAntiviral Drug Development +8

Disruption of disulfides within RBD of SARS‐CoV‐2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs

Mateja Manček‐Keber, Iva Hafner‐Bratkovič, Duško Lainšček, +9

The FASEB Journal

Spike ProteinViral Entry InhibitionMedicineViral PathogenesisImmunology +13

Multi-omics characterization of the monkeypox virus infection

Yiqi Huang, Valter Bergant, Vincent Grass, +19

Nature Communications

Cross-species analysis of viral nucleic acid interacting proteins identifies TAOKs as innate immune regulators

Friederike L. Pennemann, Assel Mussabekova, Christian Urban, +15

Nature Communications

Attenuation of <scp>SARS‐CoV</scp> ‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases

Valter Bergant, Shintaro Yamada, Vincent Grass, +26

The EMBO Journal

Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection

K Wagner, Laura M. Mateyka, Sebastian Jarosch, +29

Cell Reports

Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein

Hristo L. Svilenov, Julia Sacherl, A. Reiter, +13

Antiviral Research